Trial Profile
An observational and retrospective study assessing safety, tolerability and risk factors for treatment interruption of Nifurtimox in a cohort of adult patients with chronic Chagas disease in Colombia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Nifurtimox (Primary)
- Indications Chagas disease
- Focus Adverse reactions
- 16 May 2016 New trial record